Health

Structured treatment program for type 2 diabetes updated

20. June 2022


Photo: Andrey Popov / Adobe Stock

About 4.7 million people with compulsory health insurance who suffer from type 2 diabetes are already treated in a DMP, a structured treatment program for the chronically ill. The Federal Joint Committee (G-BA) has adapted the recommended diagnostics and therapy in type 2 diabetes mellitus DMP to the latest medical knowledge.

The changes concern, for example, recommendations for drug therapy, treatment of concomitant and secondary diseases and measures to strengthen health literacy.
Among other things, the following changes were decided:

  • Recommendations for drug therapy of blood sugar metabolism were made more precise against the background of an individually different risk of cardiovascular disease or functional disorders of the kidneys. This applies to both therapy goals and strategy and drug selection recommendations.
  • Since obesity and lack of exercise are important factors influencing the course of type 2 diabetes, DMP participants should be even more motivated to eat healthily and exercise more.
  • Given the particular importance for patients, references to the risk of hypoglycemia in daily life have also been included in the DMP requirements.

The current decision also has an impact on the DMP contractual partners: within one year of the decision coming into force, the current DMP contracts between health insurance companies, doctors’ offices and hospitals must be adapted to the new requirements.

The decision will be submitted to the Federal Ministry of Health for statutory review. In the absence of objections, the new regulations, including the appropriate documentary requirements, enter into force on the first day of the quarter following their publication in the Federal Gazette.

Background: DMP (Disease Management Programs)

The goal of the DMP is to improve the intersectoral treatment process and the quality of medical care for the chronically ill.
The Federal Joint Committee selects chronic diseases suitable for a DMP, determines the requirements for such programs, reviews them regularly, and updates them as necessary. The requirements for the DMP and documentation are regulated in the DMP requirements guideline. The practical implementation of the DMP takes place on the basis of regional contracts between health insurance companies and service providers (contract doctors / hospitals). Before concluding the contract, the Federal Social Security Office checks whether the requirements for a DMP specified in the guidelines of the G-BA are met.

About the author

hiyabad

Leave a Comment